Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric M Bachelder

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Pharmaceutical Research|November 30, 2016
Electrosprayed Myocet-like Liposomes: An Alternative to Traditional Liposome ProductionMichael A Collier, Eric M Bachelder, Kristy M Ainslie
International Journal of Pharmaceutics|February 6, 2025
Mast cell activators as adjuvants for intranasal mucosal vaccinesConnor T Murphy, Eric M Bachelder, Kristy M Ainslie
Molecular Pharmaceutics|January 30, 2024
Clinical and Preclinical Methods of Heat-Stabilization of Human VaccinesGrace L Williamson, Eric M Bachelder, Kristy M Ainslie
Trends in Molecular Medicine|April 27, 2021
Historical Perspective of Clinical Nano and Microparticle Formulations for Delivery of TherapeuticsCole J Batty, Eric M Bachelder, Kristy M Ainslie
Chemical Reviews|December 30, 2016
Acetalated Dextran: A Tunable and Acid-Labile Biopolymer with Facile Synthesis and a Range of ApplicationsEric M Bachelder, Erica N Pino, Kristy M Ainslie
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 20, 2024
Microparticle and nanoparticle-based influenza vaccinesLuis Ontiveros-Padilla, Eric M Bachelder, Kristy M Ainslie
Pharmaceutical Nanotechnology|September 20, 2018
Drug Delivery for Cancer Immunotherapy and VaccinesCole J Batty, Pamela Tiet, Eric M Bachelder, et al.
Expert Opinion on Drug Delivery|February 2, 2023
Preclinical developments in the delivery of protein antigens for vaccinationDylan A Hendy, Alex Haven, Eric M Bachelder, et al.
International Journal of Pharmaceutics|December 18, 2022
Particle-Based therapies for antigen specific treatment of type 1 diabetesNicole Rose Lukesh, Denzel D Middleton, Eric M Bachelder, et al.
Advanced Nanobiomed Research|March 8, 2021
Considerations for Size, Surface Charge, Polymer Degradation, Co-Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious DiseasesChristopher J Genito, Cole J Batty, Eric M Bachelder, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Pharmaceutical Research|November 30, 2016
Electrosprayed Myocet-like Liposomes: An Alternative to Traditional Liposome ProductionMichael A Collier, Eric M Bachelder, Kristy M Ainslie
International Journal of Pharmaceutics|February 6, 2025
Mast cell activators as adjuvants for intranasal mucosal vaccinesConnor T Murphy, Eric M Bachelder, Kristy M Ainslie
Molecular Pharmaceutics|January 30, 2024
Clinical and Preclinical Methods of Heat-Stabilization of Human VaccinesGrace L Williamson, Eric M Bachelder, Kristy M Ainslie
Trends in Molecular Medicine|April 27, 2021
Historical Perspective of Clinical Nano and Microparticle Formulations for Delivery of TherapeuticsCole J Batty, Eric M Bachelder, Kristy M Ainslie
Chemical Reviews|December 30, 2016
Acetalated Dextran: A Tunable and Acid-Labile Biopolymer with Facile Synthesis and a Range of ApplicationsEric M Bachelder, Erica N Pino, Kristy M Ainslie
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 20, 2024
Microparticle and nanoparticle-based influenza vaccinesLuis Ontiveros-Padilla, Eric M Bachelder, Kristy M Ainslie
Pharmaceutical Nanotechnology|September 20, 2018
Drug Delivery for Cancer Immunotherapy and VaccinesCole J Batty, Pamela Tiet, Eric M Bachelder, et al.
Expert Opinion on Drug Delivery|February 2, 2023
Preclinical developments in the delivery of protein antigens for vaccinationDylan A Hendy, Alex Haven, Eric M Bachelder, et al.
International Journal of Pharmaceutics|December 18, 2022
Particle-Based therapies for antigen specific treatment of type 1 diabetesNicole Rose Lukesh, Denzel D Middleton, Eric M Bachelder, et al.
Advanced Nanobiomed Research|March 8, 2021
Considerations for Size, Surface Charge, Polymer Degradation, Co-Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious DiseasesChristopher J Genito, Cole J Batty, Eric M Bachelder, et al.
Pageof 11